Jun 22
The virus, called adeno-associated virus type 2, or AAV-2, infects an estimated 80 percent of the population.
AAV-2 is a small virus that cannot replicate itself without the help of another virus, but with the help of a second virus it kills cells. In this case it effectively kills cancerous cells, and apparently, with no harmful side-effects on normal cells.” Lab results suggest that adeno-associated virus type 2, which infects the majority of the population but has no known ill effects, kills multiple types of cancer cells, yet it has no effect on healthy cells,” said Craig Meyers, a professor of microbiology and immunology at the Penn State College of Medicine in Pennsylvania.”
It is believed that AAV-2 recognizes that the cancer cells are abnormal and destroys them. This suggests that AAV-2 has great potential to be developed as an anti-cancer agent.
Continue reading »
Tagged with: cancer • genetics • medicine
Jun 14
I’m sure you’ve read a liner or two about Apple’s move to Intel. It’s been all over the media and it’s hard NOT to speculate about it, when one is a long and full-time consumer of the technology. I’m hoping people care about this, because it will have an impact on what and how we’ll end up computing for a living, and on how our ‘digital’ lives will be shaped in the future.
As a news event, it may be insignificant now, nonetheless, one fact is undeniable: it appears it’ll be increasingly difficult for us, mere mortals, to escape from the ramifications of how new technologies evolve and impact our everyday lives.
It appears Steve Jobs wants Apple NOT to remain a marginal player in the PC desktop/laptop space, after all. Having said that, don’t think I’m re-stating the obvious, because if you’ve been following Apple’s trajectory for the past few years, you’ll know it’s not such an obvious deduction to make. Apple’s moves and counter-moves with its product line have both disoriented and frustrated many in the forecasting game. Continue reading »
Tagged with: Apple • Intel • Mac • OS X
